https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

On July 11th and 12th 2019 a seminar will be held in Santander on the Spanish Science Technology and Innovation Strategy 2021-2027

8 de July de 2019

On July 11th and 12th, 2019, a seminar will be held in Santander during the Summer Courses of the Menéndez Pelayo International University (UIMP by its initials in Spanish) on the Spanish Science, Technology and Innovation Strategy 2021-2027, which will be an opportunity to learn about the progress in defining this strategy, which will be […]

Read more →

Dr Santiago Montes Moreno co-author of a chapter of the WHO blue book on classification of Hematolymphoid Tumors of the Digestive System

The first volume of the 5th edition of the series of the World Health Organization (WHO) on the classification of tumors in humans will be recently published. This series, known as the blue WHO books, is a reference for the diagnosis of neoplasms in different systems and It is an international standard for those involved in […]

Read more →

The group of hematological neoplasms and hematopoietic transplantation of the IDIVAL published a study that linked high levels of the FANCA gene with a worse prognosis in chronic lymphatic leukemia

Chronic Lymphatic Leukemia (CLL) is the most common type of leukemia in adults in the West. It mainly affects elderly patients and its incidence is expected to increase due to the progressive increase in life expectancy in our society. Today is an incurable disease, with a development that can be indolent or more aggressive. Knowing […]

Read more →

Researchers from IDIVAL have studied bacteria resistant to antibiotics isolated in transplanted patients

4 de July de 2019

Patients with solid organ transplants, due to the transplant process itself, hospital admission and immunosuppression, among other factors, are frequently colonized or infected by antibiotic resistant bacteria. In a study published recently in the Scientific Reports journal [doi: 10.1038 / s41598-019-45060-y], IDIVAL researchers belonging to the group of Epidemiology and Pathogenic and Molecular Mechanisms of […]

Read more →

Update of the Work Programs of the Horizon Program for 2020

The European Commission has published the update of the Work Programs of the Horizon 2020 program for 2020. Among the Programs published the Social Challenge 1 can be found: Health, Demographic Change and Welfare through which they will be financed, with a budget of 660 million €, collaborative projects, complementary actions and coordination through different […]

Read more →

INNOVATIVE MEDICINES INITIATIVE 2 FUNDING OPPORTUNITIES – JUNE 2019

28 de June de 2019

The Call gives researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.  Why apply?  Obtain research funding  Take part in scientifically excellent, patient-centric research  Join unique consortia involving top teams from industry, academia, SMEs, regulators, and others  Benefit […]

Read more →

Cerebral molecular image with 11C-PIB PETCT in the evolution of cognitive impairment

24 de June de 2019

Last May, the British journal “Nuclear Medicine Communications” published the work entitled “A 5-year longitudinal evaluation in patients with mild cognitive impairment by 11C-PIB PET / CT: a visual analysis” that gathers results of the longitudinal study that the Service of Nuclear Medicine of the University Hospital Marqués de Valdecilla (HUMV) and the Molecular Imaging […]

Read more →

Dr Valentín Fuster awarded by IDIVAL for his research career

20 de June de 2019

Within the framework of the XIIth Inter-regional Health Meeting organized at the Menéndez Pelayo International University by Joaquín Cayón, Head of Legal Services of the Ministry of Health of the Government of Cantabria, and Jorge Tomillo, Professor of Commercial Law of the University of Cantabria; the Health Counselor, María Luisa del Real has granted Dr. […]

Read more →

Valdecilla and IDIVAL discover a genetic variant that protects against Alzheimers and various forms of dementia

16 de June de 2019

Researchers of the Marqués de Valdecilla University Hospital and the Valdecilla Sanitary Research Institute Foundation (IDIVAL) have discovered that a genetic variant in the PLCG2 gene protects against several forms of dementia. According to the results of the study, carried out in collaboration with researchers from the UMC University of Amsterdam, this genetic variation not […]

Read more →

Next Conference Santander Biomedical Lectures

12 de June de 2019

The next conference of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and IBBTEC will take place on the 20th of June. The session will be given by Martin O’Halloran and will be about: “Medical Device Innovation Programmes in Ireland”. Dr Martin O'Halloran is a Senior Lecturer in Medical Electronics at […]

Read more →